Photo Credit: Upper Left Photography

Innovative Targeting Solutions Awarded 2017 Growth Stage Company of the Year

Vancouver, BC – April 19th, 2017 – Innovative Targeting Solutions Inc. (ITS) has been recognized as the “Growth Stage Life Sciences Company of the Year”, by LifeSciences B.C. The award is given to an early stage life sciences company which has demonstrated outstanding performance and achieved significant milestones in 2016 and positioned itself well for potential future commercial success through key transaction and strategic advancements in the health care sector. The award will be presented at the 19th Annual LifeSciences B.C. Awards dinner.

ITS would like to thank Blake, Cassels & Graydon LLP, Gowling WLG, KSA chartered accounts, Discovery Parks and Ceridian Canada for their contributions to the company’s growth and success. We also want to acknowledge the Federal and Provincial programs including NRC’s Industrial Research Assistance Program, the Scientific Research and Experimental Development Tax Incentive Program and the Small Business Venture Capital Tax Credit program which were all critical to getting ITS through the early stages of the company’s development.

About Innovative Targeting Solutions Inc.

Innovative Targeting Solutions Inc. is a privately-held company that has developed a next generation protein engineering platform for the generation of fully human antibody and T cell receptor based therapeutics using its proprietary HuTARG technology. The HuTARG technology is a fully mammalian technology that generates antibody diversity in vitro via RAG1/RAG2 mediated V(D)J recombination.


Susan Ogilvie,
Manager, Communications & External Affairs
LifeSciences BC
Office: 604-669-9909 EXT. 6

Paul Kang
Innovative Targeting Solutions

ITS Press Release 2017-04-19 – Life Sciences BC